| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
117,164 |
108,794 |
$9.10M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
21,178 |
20,728 |
$2.24M |
| 80050 |
General health panel |
47,633 |
46,689 |
$1.96M |
| 87631 |
|
13,397 |
13,065 |
$1.82M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
46,272 |
35,714 |
$1.73M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
71,885 |
70,308 |
$1.73M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
28,503 |
25,228 |
$1.60M |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
2,634 |
2,574 |
$1.54M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
64,822 |
63,325 |
$1.49M |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
41,572 |
40,292 |
$1.36M |
| 80061 |
Lipid panel |
98,992 |
97,088 |
$1.26M |
| 80053 |
Comprehensive metabolic panel |
119,596 |
111,655 |
$1.19M |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
37,025 |
36,529 |
$1.07M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
19,066 |
16,442 |
$1.06M |
| 84443 |
Thyroid stimulating hormone (TSH) |
47,584 |
46,190 |
$898K |
| 87800 |
|
36,373 |
35,240 |
$799K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
21,696 |
21,412 |
$790K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
24,524 |
24,037 |
$638K |
| 86480 |
|
8,712 |
8,510 |
$565K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
102,803 |
93,230 |
$532K |
| 88342 |
|
12,286 |
9,847 |
$504K |
| 88307 |
|
12,122 |
10,700 |
$482K |
| 86803 |
|
27,027 |
26,535 |
$481K |
| 86780 |
|
27,995 |
27,321 |
$394K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
53,513 |
50,851 |
$391K |
| 80081 |
|
4,728 |
4,645 |
$361K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
57,411 |
56,028 |
$348K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,073 |
9,564 |
$343K |
| 87653 |
|
8,601 |
8,458 |
$323K |
| 82728 |
|
26,536 |
25,710 |
$290K |
| 86003 |
|
3,004 |
2,783 |
$271K |
| 84466 |
|
17,058 |
16,586 |
$255K |
| 87536 |
|
2,465 |
2,415 |
$250K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
31,521 |
26,985 |
$230K |
| 85027 |
|
34,234 |
32,064 |
$212K |
| 86706 |
|
17,266 |
16,863 |
$205K |
| 87522 |
Neg quan hep c or qual rna |
5,959 |
5,750 |
$201K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
595 |
560 |
$201K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
6,201 |
6,043 |
$201K |
| 86235 |
|
4,800 |
4,627 |
$199K |
| 82607 |
|
17,223 |
16,667 |
$188K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
30,717 |
27,881 |
$184K |
| 80074 |
|
4,287 |
4,132 |
$176K |
| 88341 |
|
3,787 |
3,111 |
$172K |
| 83970 |
|
4,776 |
4,641 |
$171K |
| 84702 |
|
11,234 |
8,997 |
$171K |
| 86618 |
|
5,483 |
5,379 |
$167K |
| 84403 |
|
6,484 |
6,330 |
$163K |
| 84439 |
|
21,031 |
20,327 |
$147K |
| 87340 |
|
10,972 |
10,744 |
$147K |
| 82570 |
|
23,270 |
22,663 |
$143K |
| 83540 |
|
19,367 |
18,811 |
$143K |
| 88112 |
|
2,953 |
2,326 |
$140K |
| 88360 |
|
2,025 |
1,606 |
$135K |
| 84153 |
|
5,948 |
5,818 |
$126K |
| 82043 |
|
18,356 |
18,024 |
$125K |
| 86038 |
|
8,167 |
7,970 |
$114K |
| 87186 |
|
15,654 |
15,025 |
$112K |
| 87077 |
|
16,279 |
15,631 |
$107K |
| 82784 |
|
6,840 |
6,649 |
$107K |
| 83655 |
|
10,374 |
10,204 |
$106K |
| 87507 |
|
839 |
819 |
$105K |
| 84146 |
|
4,596 |
4,490 |
$103K |
| 88304 |
|
8,866 |
7,613 |
$99K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
2,664 |
2,645 |
$99K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
213 |
207 |
$95K |
| 86704 |
|
6,858 |
6,699 |
$95K |
| 83735 |
|
16,067 |
13,784 |
$91K |
| 81001 |
|
34,618 |
33,251 |
$91K |
| 86708 |
|
6,591 |
6,429 |
$89K |
| 86360 |
|
1,489 |
1,459 |
$85K |
| 86696 |
|
3,852 |
3,768 |
$85K |
| 83001 |
|
5,016 |
4,905 |
$82K |
| 84270 |
|
3,334 |
3,260 |
$80K |
| 85610 |
|
23,354 |
14,510 |
$77K |
| 88189 |
|
1,106 |
1,047 |
$76K |
| 82670 |
|
3,766 |
3,668 |
$76K |
| 86225 |
|
4,911 |
4,805 |
$67K |
| 86160 |
|
3,152 |
3,060 |
$67K |
| 86359 |
|
1,492 |
1,462 |
$67K |
| 88312 |
|
1,439 |
1,103 |
$66K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
371 |
356 |
$62K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,617 |
1,567 |
$60K |
| 88313 |
|
2,143 |
1,875 |
$60K |
| 86695 |
|
3,098 |
3,039 |
$59K |
| 84481 |
|
2,844 |
2,781 |
$58K |
| 36415 |
Collection of venous blood by venipuncture |
97,991 |
82,463 |
$58K |
| 82746 |
|
6,104 |
5,904 |
$58K |
| 83525 |
|
5,352 |
5,216 |
$56K |
| 86665 |
|
1,696 |
1,658 |
$56K |
| 86200 |
|
4,076 |
4,010 |
$55K |
| 83002 |
|
3,397 |
3,327 |
$54K |
| 85652 |
|
19,654 |
18,819 |
$54K |
| 86140 |
|
19,122 |
17,992 |
$54K |
| 82105 |
|
2,946 |
2,847 |
$53K |
| 81329 |
|
593 |
563 |
$53K |
| 81514 |
|
761 |
738 |
$52K |
| 88141 |
|
7,658 |
7,567 |
$51K |
| 84165 |
|
4,392 |
3,997 |
$51K |
| 81003 |
|
17,937 |
17,511 |
$49K |
| 80164 |
|
3,434 |
3,191 |
$48K |
| 83880 |
|
1,789 |
1,647 |
$47K |
| 87634 |
|
673 |
658 |
$44K |
| 86147 |
|
779 |
762 |
$44K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
2,181 |
2,148 |
$43K |
| 87081 |
|
8,341 |
8,070 |
$43K |
| 86039 |
|
2,950 |
2,891 |
$41K |
| 86617 |
|
1,412 |
1,364 |
$40K |
| 86800 |
|
2,392 |
2,338 |
$40K |
| 86431 |
|
5,506 |
5,412 |
$39K |
| 82950 |
|
5,959 |
5,866 |
$38K |
| 86762 |
|
2,057 |
1,998 |
$37K |
| 80076 |
|
4,537 |
4,309 |
$37K |
| 87070 |
|
5,572 |
5,294 |
$35K |
| 82627 |
|
1,682 |
1,651 |
$34K |
| 81374 |
|
522 |
501 |
$34K |
| 86850 |
|
4,186 |
3,950 |
$33K |
| 86664 |
|
1,640 |
1,611 |
$31K |
| 88311 |
|
2,278 |
1,811 |
$31K |
| 83021 |
|
1,600 |
1,532 |
$30K |
| 82977 |
|
3,897 |
3,515 |
$29K |
| 84100 |
|
5,682 |
4,808 |
$29K |
| 84156 |
|
7,727 |
7,089 |
$29K |
| 86663 |
|
1,647 |
1,618 |
$27K |
| 86787 |
|
1,622 |
1,559 |
$27K |
| 84550 |
|
4,992 |
4,705 |
$26K |
| 87209 |
|
1,341 |
1,143 |
$26K |
| 82248 |
|
5,143 |
4,702 |
$26K |
| 86146 |
|
588 |
572 |
$26K |
| 82533 |
|
2,254 |
2,109 |
$26K |
| 83498 |
|
1,244 |
1,216 |
$25K |
| 88173 |
|
754 |
629 |
$23K |
| 84460 |
|
3,548 |
3,462 |
$23K |
| 88142 |
|
1,440 |
1,431 |
$23K |
| 86376 |
|
2,999 |
2,939 |
$23K |
| 88302 |
|
2,451 |
2,234 |
$23K |
| 84630 |
|
1,795 |
1,753 |
$22K |
| 87529 |
|
1,003 |
976 |
$22K |
| 82550 |
|
3,481 |
3,276 |
$22K |
| 84480 |
|
2,994 |
2,889 |
$22K |
| 87205 |
|
5,254 |
4,986 |
$21K |
| 82951 |
|
1,697 |
1,667 |
$21K |
| 80197 |
|
1,902 |
1,288 |
$20K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,275 |
2,153 |
$20K |
| 84590 |
|
1,545 |
1,513 |
$19K |
| 86705 |
|
1,238 |
1,220 |
$19K |
| 84436 |
|
2,561 |
2,487 |
$18K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
398 |
388 |
$18K |
| 82024 |
|
468 |
451 |
$17K |
| 83993 |
|
850 |
830 |
$17K |
| 86900 |
|
4,460 |
4,226 |
$17K |
| 86901 |
|
4,367 |
4,136 |
$17K |
| 85730 |
|
2,778 |
2,670 |
$17K |
| 86318 |
|
1,005 |
987 |
$17K |
| 84144 |
|
1,149 |
1,057 |
$17K |
| 87902 |
|
187 |
178 |
$16K |
| 88309 |
|
359 |
319 |
$16K |
| 84425 |
|
2,250 |
2,192 |
$16K |
| 84305 |
|
653 |
638 |
$15K |
| 87075 |
|
1,637 |
1,591 |
$15K |
| 80069 |
|
1,983 |
1,821 |
$15K |
| 87088 |
|
1,995 |
1,942 |
$15K |
| 87147 |
|
4,265 |
4,145 |
$14K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
21,893 |
13,588 |
$14K |
| 87517 |
|
399 |
379 |
$14K |
| 84432 |
|
664 |
642 |
$14K |
| 84445 |
|
675 |
658 |
$14K |
| 86364 |
|
2,689 |
2,626 |
$13K |
| 83921 |
|
813 |
788 |
$13K |
| 84166 |
|
825 |
737 |
$13K |
| 84207 |
|
395 |
377 |
$13K |
| 87493 |
|
375 |
371 |
$13K |
| 83690 |
|
2,761 |
2,668 |
$13K |
| 84154 |
|
766 |
749 |
$13K |
| 82247 |
|
1,893 |
1,318 |
$12K |
| 86765 |
|
1,092 |
1,057 |
$12K |
| 80178 |
|
1,856 |
1,581 |
$12K |
| 87486 |
|
325 |
317 |
$12K |
| 82785 |
|
721 |
707 |
$12K |
| 82565 |
|
2,099 |
1,592 |
$11K |
| 80177 |
|
978 |
929 |
$11K |
| 83615 |
|
1,815 |
1,588 |
$11K |
| 82274 |
|
3,507 |
3,420 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
115 |
109 |
$10K |
| 84402 |
|
404 |
393 |
$10K |
| 87177 |
|
1,339 |
1,143 |
$10K |
| 84134 |
|
533 |
474 |
$9K |
| 82378 |
|
624 |
525 |
$9K |
| 83721 |
|
1,011 |
964 |
$9K |
| 85007 |
|
2,124 |
2,057 |
$9K |
| 87581 |
|
477 |
466 |
$8K |
| 86255 |
|
363 |
359 |
$8K |
| 82947 |
|
2,241 |
2,180 |
$8K |
| 85045 |
|
1,843 |
1,746 |
$8K |
| 86769 |
|
452 |
440 |
$7K |
| 86008 |
|
109 |
96 |
$7K |
| 85379 |
|
765 |
728 |
$7K |
| 85613 |
|
579 |
566 |
$6K |
| 82575 |
|
609 |
594 |
$6K |
| 88331 |
|
252 |
229 |
$6K |
| 84450 |
|
925 |
900 |
$6K |
| 82330 |
|
708 |
640 |
$6K |
| 87338 |
|
951 |
932 |
$6K |
| 82652 |
|
128 |
125 |
$5K |
| 82525 |
|
473 |
457 |
$5K |
| 86334 |
|
282 |
274 |
$5K |
| 84681 |
|
201 |
198 |
$5K |
| 86592 |
|
1,393 |
1,349 |
$5K |
| 86036 |
|
485 |
467 |
$5K |
| 88300 |
|
1,268 |
1,137 |
$5K |
| 83516 |
|
656 |
598 |
$5K |
| 82952 |
|
1,412 |
1,388 |
$5K |
| 82150 |
|
1,011 |
972 |
$4K |
| 81596 |
|
98 |
94 |
$4K |
| 83521 |
|
239 |
226 |
$4K |
| 85018 |
|
1,723 |
1,548 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
275 |
265 |
$4K |
| 81015 |
|
1,546 |
1,520 |
$4K |
| 88333 |
|
92 |
84 |
$4K |
| 86645 |
|
177 |
171 |
$4K |
| 83520 |
|
427 |
403 |
$4K |
| 86709 |
|
260 |
252 |
$4K |
| 82088 |
|
142 |
134 |
$3K |
| 82164 |
|
181 |
178 |
$3K |
| 87563 |
|
122 |
120 |
$3K |
| 86644 |
|
182 |
176 |
$3K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
36 |
30 |
$3K |
| 84155 |
|
775 |
748 |
$3K |
| 82310 |
|
520 |
488 |
$3K |
| 86812 |
|
243 |
236 |
$3K |
| 80175 |
|
228 |
224 |
$3K |
| 87481 |
|
103 |
92 |
$3K |
| 80156 |
|
163 |
149 |
$3K |
| 85245 |
|
84 |
81 |
$2K |
| 86304 |
|
131 |
111 |
$2K |
| 89051 |
|
376 |
295 |
$2K |
| 85014 |
|
1,056 |
900 |
$2K |
| 82140 |
|
504 |
461 |
$2K |
| 87102 |
|
252 |
240 |
$2K |
| 87101 |
|
220 |
219 |
$2K |
| 86015 |
|
232 |
225 |
$2K |
| 82085 |
|
232 |
226 |
$2K |
| 82390 |
|
209 |
204 |
$2K |
| 86308 |
|
277 |
274 |
$2K |
| 86735 |
|
432 |
415 |
$2K |
| 84244 |
|
139 |
133 |
$2K |
| 84478 |
|
248 |
228 |
$2K |
| 82672 |
|
110 |
108 |
$1K |
| 86300 |
|
61 |
51 |
$1K |
| 83835 |
|
108 |
98 |
$1K |
| 83010 |
|
118 |
113 |
$1K |
| 84520 |
|
272 |
264 |
$1K |
| 86317 |
|
20 |
14 |
$1K |
| 82103 |
|
77 |
70 |
$1K |
| 81511 |
|
12 |
12 |
$1K |
| 85246 |
|
38 |
37 |
$1K |
| 82955 |
|
127 |
127 |
$1K |
| 82239 |
|
68 |
58 |
$991.08 |
| 88344 |
|
16 |
16 |
$991.08 |
| 82157 |
|
39 |
38 |
$974.93 |
| 81025 |
|
240 |
232 |
$960.70 |
| 88377 |
|
18 |
15 |
$938.77 |
| 87220 |
|
241 |
240 |
$924.69 |
| 87641 |
|
31 |
31 |
$853.51 |
| 86593 |
|
127 |
121 |
$708.26 |
| 86341 |
|
26 |
25 |
$689.31 |
| 87497 |
|
24 |
12 |
$676.80 |
| 84132 |
|
118 |
104 |
$638.98 |
| 85097 |
|
40 |
39 |
$632.88 |
| 81241 |
|
12 |
12 |
$596.97 |
| 87521 |
Neg quan hep c or qual rna |
14 |
14 |
$550.22 |
| 85240 |
|
44 |
42 |
$537.86 |
| 86381 |
|
69 |
67 |
$527.47 |
| 81050 |
|
408 |
398 |
$503.93 |
| 86141 |
|
52 |
50 |
$502.10 |
| 82653 |
|
27 |
26 |
$476.34 |
| 86256 |
|
55 |
52 |
$456.09 |
| 82787 |
|
13 |
13 |
$415.92 |
| 84484 |
|
47 |
41 |
$390.90 |
| 87110 |
|
16 |
16 |
$378.14 |
| 89060 |
|
52 |
48 |
$320.66 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
156 |
128 |
$315.54 |
| 82040 |
|
113 |
105 |
$310.71 |
| 87329 |
|
24 |
24 |
$290.92 |
| 87045 |
|
38 |
37 |
$254.91 |
| 86231 |
|
28 |
28 |
$243.57 |
| 87076 |
|
25 |
24 |
$195.72 |
| 84145 |
|
26 |
25 |
$183.10 |
| 85660 |
|
59 |
58 |
$179.03 |
| 82340 |
|
25 |
25 |
$175.70 |
| 86611 |
|
12 |
12 |
$159.09 |
| 87040 |
|
14 |
12 |
$145.38 |
| 87107 |
|
12 |
12 |
$142.17 |
| 82397 |
|
27 |
27 |
$128.35 |
| 86666 |
|
12 |
12 |
$119.71 |
| 87449 |
|
29 |
28 |
$110.29 |
| 87324 |
|
28 |
27 |
$110.29 |
| 83605 |
|
15 |
15 |
$100.32 |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
3,894 |
2,259 |
$98.67 |
| 82945 |
|
27 |
24 |
$93.44 |
| 86060 |
|
13 |
13 |
$84.16 |
| 84300 |
|
14 |
12 |
$80.30 |
| 82465 |
|
14 |
14 |
$79.63 |
| 85004 |
|
15 |
12 |
$61.12 |
| 89055 |
|
13 |
12 |
$54.00 |
| 84075 |
|
12 |
12 |
$53.07 |
| 82438 |
|
15 |
15 |
$48.90 |
| 87140 |
|
16 |
16 |
$45.62 |
| 86682 |
|
38 |
38 |
$8.46 |
| 36416 |
|
346 |
241 |
$3.41 |